Puma Biotechnology (PBYI) PT Lowered to $24 at Goldman Sachs
Tweet
Share
E-mail
Get Alerts PBYI Hot Sheet
Price: $8.26 +3.38%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Goldman Sachs analyst Paul Choi lowered the price target on Puma Biotechnology (NASDAQ: PBYI) to $24.00 (from $29.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Societe BIC SA (BB:FP) (BICEY) PT Raised to EUR56 at UBS
- Pembina Pipeline Corp. (PPL:CN) (PBA) PT Raised to Cdn$73 at CIBC
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
